In Vivo Pharmacodynamic Profile of EVER206, a Novel Polymyxin Antimicrobial, against Gram-Negative Bacteria in the Murine Thigh Infection Model
Antimicrobial Agents and Chemotherapy · 2023
DOI: 10.1128/aac.01738-22 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von Christian M Gill und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, Connecticut, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Anti-Infective Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Everest Medicines.
Abstract (Originalsprache)
The objective was to determine the magnitude of the EVER206 free-plasma area under the concentration time curve ( f AUC)/MIC target associated with bacteriostasis and 1-log 10 kill against clinically relevant Gram-negative bacteria in the murine thigh model. Twenty-seven clinical isolates ( Pseudomonas aeruginosa , n = 10; Escherichia coli , n = 9; Klebsiella pneumoniae , n = 5; Enterobacter cloacae , n = 2; and Klebsiella aerogenes , n = 1) were tested.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, Connecticut, USA.
- Division of Infectious Diseases, Hartford Hospital, Hartford, Connecticut, USA.
ORCID-Profile: Christian M Gill, David P Nicolau
Förderung
- Everest Medicines
Zitieren
APA
Gill, C. M., & Nicolau, D. P. (2023). In Vivo Pharmacodynamic Profile of EVER206, a Novel Polymyxin Antimicrobial, against Gram-Negative Bacteria in the Murine Thigh Infection Model. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01738-22
Vancouver
Gill CM, Nicolau DP. In Vivo Pharmacodynamic Profile of EVER206, a Novel Polymyxin Antimicrobial, against Gram-Negative Bacteria in the Murine Thigh Infection Model. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.01738-22
BibTeX
@article{Gill2023,
author = {Gill, Christian M and Nicolau, David P},
title = {In Vivo Pharmacodynamic Profile of EVER206, a Novel Polymyxin Antimicrobial, against Gram-Negative Bacteria in the Murine Thigh Infection Model},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2023},
doi = {10.1128/aac.01738-22}
}
EUVIMED